-
-
-
-
-
-
-
OKYO Pharma Announces First-Patient First-Visit for Phase 2 Trial Evaluating Efficacy and Safety of OK-101 in Patients with Dry Eye Disease
-
-
-
-
-
-
-
OKYO Pharma Limited (OKYO) Files for a US IPO
-
-
-
-
1,160,143 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

